A covalent inhibitor targeting Cys-349 of LIMK1 confers selectivity over LIMK2 - Jon B. Patteson; Ioannis Manolaridis; Mee Ra Hong; Jennifer M. Johnston; Samaneh Mesbahi-Vasey; Michael C. Gregory; Daniel V. Iwamoto; John C. Reid; John M. Sanders; Ditte Lovatt; Terrence P. McDonald; Valerie W. Shurtleff; et al. (Journal of Biological Chemistry, 2026)